The role of doxycycline in the therapy of multidrug-resistant E. coli – an in vitro study
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The role of doxycycline in the therapy of multidrug-resistant E. coli – an in vitro study
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-08-18
DOI
10.1038/srep31964
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- National epidemiology of carbapenem-resistant and extensively drug-resistant Gram-negative bacteria isolated from blood samples in China in 2013
- (2016) A. Xu et al. CLINICAL MICROBIOLOGY AND INFECTION
- Co-existence ofblaNDM-1andblaKPC-2in clinical isolates ofKlebsiella pneumoniaefrom Pakistan
- (2016) Haseeb Sattar et al. JOURNAL OF CHEMOTHERAPY
- Colistin-sparing regimens against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae isolates: Combination of tigecycline or doxycycline and gentamicin or amikacin
- (2016) Hung-Jen Tang et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Double- and multi-carbapenemase-producers: the excessively armored bacilli of the current decade
- (2015) G. Meletis et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Tetracyclines for multidrug-resistant Acinetobacter baumannii infections
- (2015) Matthew E. Falagas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Coexistence of a novel KPC-2-encoding MDR plasmid and an NDM-1-encoding pNDM-HN380-like plasmid in a clinical isolate ofCitrobacter freundii
- (2015) Jiao Feng et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Coproduction of NDM-1 and KPC-2 inEnterobacter hormaecheifrom Brazil
- (2015) Polyana Silva Pereira et al. Microbial Drug Resistance
- Carbapenemase-Producing Enterobacteriaceae
- (2015) David Paterson et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- In vitro Susceptibility of Tigecycline against Multidrug-Resistant Gram-Negative Strains: Etest versus Agar Dilution
- (2015) Sezen Özkök et al. CHEMOTHERAPY
- Unusual association of NDM-1 with KPC-2 and armA among Brazilian Enterobacteriaceae isolates
- (2014) M.G. Quiles et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Treating infections caused by carbapenemase-producing Enterobacteriaceae
- (2014) L.S. Tzouvelekis et al. CLINICAL MICROBIOLOGY AND INFECTION
- Emergence of Carbapenem-ResistantEscherichia Coliin Taiwan: Resistance Due to Combined CMY-2 Production and Porin Deficiency
- (2014) J.H. Chia et al. JOURNAL OF CHEMOTHERAPY
- Characterization of Porin Expression in Klebsiella pneumoniae Carbapenemase (KPC)-Producing K. pneumoniae Identifies Isolates Most Susceptible to the Combination of Colistin and Carbapenems
- (2013) Jae H. Hong et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Updated molecular epidemiology of carbapenem-non-susceptible Escherichia coli in Taiwan: first identification of KPC-2 or NDM-1-producing E. coliin Taiwan
- (2013) Ling Ma et al. BMC INFECTIOUS DISEASES
- Treatment Outcome of Bacteremia Due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens
- (2012) Zubair A. Qureshi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy
- (2012) M. Tumbarello et al. CLINICAL INFECTIOUS DISEASES
- Combination Therapy for Treatment of Infections with Gram-Negative Bacteria
- (2012) P. D. Tamma et al. CLINICAL MICROBIOLOGY REVIEWS
- Trends in the Susceptibility of Clinically Important Resistant Bacteria to Tigecycline: Results from the TigecyclineIn VitroSurveillance in Taiwan Study, 2006 to 2010
- (2011) Yen-Hsu Chen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Appraising Contemporary Strategies to Combat Multidrug Resistant Gram-Negative Bacterial Infections–Proceedings and Data From the Gram-Negative Resistance Summit
- (2011) Marin H. Kollef et al. CLINICAL INFECTIOUS DISEASES
- Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment
- (2011) O. Zarkotou et al. CLINICAL MICROBIOLOGY AND INFECTION
- Therapeutic options for infections withEnterobacteriaceaeproducing carbapenem-hydrolyzing enzymes
- (2011) Matthew E Falagas et al. Future Microbiology
- Emergence of Klebsiella pneumoniae isolate co-producing NDM-1 with KPC-2 from India
- (2011) K. Kumarasamy et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Current Concepts in Antimicrobial Therapy Against Resistant Gram-Negative Organisms: Extended-Spectrum β-Lactamase–Producing Enterobacteriaceae, Carbapenem-Resistant Enterobacteriaceae, and Multidrug-Resistant Pseudomonas aeruginosa
- (2011) Souha S. Kanj et al. MAYO CLINIC PROCEEDINGS
- Treatment of Recurrent Stenotrophomonas maltophilia Ventilator-Associated Pneumonia with Doxycycline and Aerosolized Colistin
- (2010) G. C. Wood et al. ANNALS OF PHARMACOTHERAPY
- Detection of NDM-1-ProducingKlebsiella pneumoniaein Kenya
- (2010) Laurent Poirel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection
- (2010) Elizabeth B. Hirsch et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started